Blog - Page 1241 of 5761

FridayOct 08, 2021 2:21 pm

Podcast Interview Highlights POC Health Data Testing Using Innovative Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Platform

Pharmacy services developer Avricore Health recently completed the initial phase of rolling out its HealthTab(TM) platform HealthTab(TM) partners with other health technology platforms to collect data from blood or other molecular samples to test them for illnesses ranging from COVID and flu to heart disease and diabetes Avricore’s platform is designed to not only provide medical condition information to patients, but to share it seamlessly with medical providers and researchers The company’s initial rollout took place through pharmacies in Ontario, Canada, but Avricore intends to continue expanding throughout Canada, into the United States and eventually into Europe Health diagnostics technology…

FridayOct 08, 2021 1:47 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Launch of New Website and Resources

Tryp Therapeutics recently launched a new website with updated resources to be featured on the site Over the next few weeks, the company will share key resources that will be the standout features of the new website Tryp believes that the new features represent expanded knowledge of the company’s strategy and will present more opportunities to existing investors and bring in more individuals who share in its course Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) has, since its inception, led the next wave of psychedelic drug development beyond mental health. Its focus on areas of high unmet medical needs and bring…

FridayOct 08, 2021 1:33 pm

FingerMotion Inc. (FNGR): A Future Anchored in Mobile Products Research and Development

FingerMotion’s R&D expenditure has been gradually increasing quarter over quarter and year on year, representing its focus on the development of innovative mobile payment and communication products for over 1/2 million users in China The company’s Big Data Insights division, Sapientus, which has accounted for most of the R&D expenditure so far, has been several years in the making FingerMotion is looking to establish a collaborative lab with partners to run as a joint research and analytics hub In March 2020, FNGR set aside resources dedicated to the R&D of an RCS platform A look at several of the recent…

FridayOct 08, 2021 1:15 pm

QualityStocksNewsBreaks – Why DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Is ‘One to Watch’

DigiMax Global (CSE: DIGI) (OTC: DBKSF) is an artificial intelligence technology and services company producing and leveraging predictive indicators across various industries and verticals. The company’s core solutions include CryptoHawk AI — A deep learning AI solution (“SaaS”) that monitors and analyzes live select cryptocurrencies and financial markets; Cryptocurrency Hedge Fund — A long/short cryptocurrency hedge fund for high net worth, institutional and family office clients; Projected Personality Interpreter (“PPI”) — A solution utilizing AI to provide comparative insights for better hiring decisions, reduced employment attrition, improved workplace culture, and augmented human and financial predictive services; and Navee Predict — An…

FridayOct 08, 2021 12:45 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Outcome of NIC-A21-1 Study Using DehydraTECH(TM)-Nicotine Pouches

The company believes that the study findings support its patented DehydraTECH(TM) system as being the world’s fastest-acting nicotine through oral absorption and a safer nicotine alternative for the 1.1 billion smokers of the world Plans for a human trial are in the design process, and Lexaria intends to use existing capital to execute the study The global nicotine pouch market is expected to grow to a total revenue of $21.84 billion by the end of 2027, a CAGR growth of 30.7% over the forecast period A leader in innovative drug delivery platforms, Lexaria Bioscience (NASDAQ: LEXX) has announced the results…

FridayOct 08, 2021 12:37 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Committed to Becoming True ‘Farm-to-Door’ Cannabis Company

Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis sector, recently updated its current and prospective shareholders to cover key milestones in the company’s strategic plan. The update included details on its growing Nug Avenue operations and additional strides toward verticalizing its model through the acquisition of California cannabis licenses and potentially establishing commercial operations in the cannabis delivery market outside of the state of California. Sugarmade CEO Jimmy Chan described as “tangible” the strides the company continues to make toward a vertically integrated model. “Our long-term strategic vision is to establish the capacity to control all aspects of…

FridayOct 08, 2021 12:13 pm

QualityStocksNewsBreaks – Simply Sonoma Primed to Benefit from Projected Billion-Dollar Growth of CBD Space

Simply Sonoma, a CBD company focused on building a reputation as a leader in plant-based medicinal health and beauty products, is poised to benefit from the projected billion-dollar growth of the CBD space. This is according to a recent article discussing analysis by Yahoo.finance in a publication titled “CBD Market to Grow to $16 Billion by 2026 — Should You Invest?” The article, which contains excerpts from the publication, reports that increasing awareness of CBD’s therapeutic benefits has influenced buyers to purchase cannabidiol (“CBD”) products, in turn influencing commercial retailers, including those in health and wellness sectors, to now focus…

FridayOct 08, 2021 11:51 am

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Poised as Ideal Partner in Post-Pandemic Insurance Space in China

FingerMotion (OTCQX: FNGR) is a technology company with core competencies in SMS/MMS services, mobile payment and recharge solutions, and big data insights. Following revelations that the pandemic posed a significant challenge to the adaptability and resilience of insurance companies and their management teams, Deloitte China proposed that insurers apply big data to facilitate product differentiation and build digital operational capabilities to ensure longevity post-pandemic. In this regard, FingerMotion appears poised as an ideal partner for insurers looking to implement Deloitte China’s proposals. Through its big data insights division (“Sapientus”), which provides behavioral analytics sourced from publicly available data, FNGR is…

FridayOct 08, 2021 11:35 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Poised to Become Global Leader in Manufacture of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM) recently announced it had signed a definitive agreement to acquire 100% of BayMedica Inc., a U.S.-based private company specializing in the manufacture and commercialization of rare cannabinoids. InMed CEO Eric A. Adams described the acquisition as a transformative transaction for the company as it would give InMed a breadth of synthetic cannabinoid manufacturing capabilities. “BayMedica brings unparalleled cannabinoid manufacturing expertise in both chemical synthesis and biosynthesis together with industry veterans who have been pioneers in this space,” a recent article quotes Adams as saying. The article further notes that, once closed, the transaction will create a…

FridayOct 08, 2021 11:29 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces New Executives, Internal Promotions

Cybin names Dr. Amir Inamdar as chief medical officer for European operations The company appoints Dr. Geoff Varty as head of research and development Both professionals bring decades of expertise to their new roles as Cybin focuses on progressing psychedelic therapeutics As Cybin (NEO: CYBN) (NYSE American: CYBN) continues its commitment to focus on the psychedelic therapeutic space and deliver proprietary drug-discovery platforms, the company has made key additions and changes (https://ibn.fm/0GBMQ). Most recently the company has appointed two new executives and announced internal promotions to continue strengthening its leadership team. Cybin has named Dr. Amir Inamdar as chief medical…

Site Search

Company Search